[Chronic bronchopneumopathies in chest x-ray findings at the Centro di Medicina Preventiva e Sociale]

Area of Science:

• Pediatrics
• Pulmonology
• Preventive Medicine

Background:

• Chronic bronchopneumopathy presents a significant health concern, particularly in pediatric populations.
• Untreated chronic bronchopneumopathy can progress to chronic respiratory insufficiency in adulthood.
• The V. Monaldi Hospital Preventive and Social Medicine Centre in Naples identified a notable incidence of this condition.

Purpose of the Study:

• To assess the incidence of chronic bronchopneumopathy in secondary school children and the general population.
• To investigate the long-term implications of untreated chronic bronchopneumopathy.
• To evaluate the efficacy of specific pharmacological interventions for managing the condition.

Main Methods:

• Screening of secondary school children and the general population at a specific medical center.
• Observational study to track the progression of chronic bronchopneumopathy.
• Clinical evaluation of therapeutic interventions, including anti-inflammatory and anti-bronchospastic agents.

Main Results:

• A significant incidence of chronic bronchopneumopathy was detected, especially among infants.
• Diethyl-aminoethoxyethylic ester of alpha-phenylbutyric acid demonstrated success as an anti-inflammatory and anti-bronchospastic agent.
• Preventive strategies targeting infants and the elderly are recommended.

Conclusions:

• Early detection and intervention for chronic bronchopneumopathy are crucial for preventing adult respiratory insufficiency.
• Pharmacological treatment, particularly with specific ester compounds, offers a viable therapeutic approach.
• Preventive and social medicine management should prioritize high-risk groups, including infants and the elderly.